Table 3 Test-retest reliability for electroencephalography-based and reaction time measures in community control and clinical high risk groups.
Measure | Electrodes included in average | Community Control (n = 84) | Clinical High Risk (n = 571) |
|---|---|---|---|
G-coefficienta | G-coefficient | ||
Event-related potential measures | |||
AODb Target P300 (P3b) | CPz, CP1, CP2, Pz, P1, P2 | 0.66 | 0.72 |
AOD Novel P300 (P3a) | FCz, FC1, FC2, Cz, C1, C2 | 0.74 | 0.70 |
VODc Target P300 (P3b) | CPz, CP1, CP2, Pz, P1, P2 | 0.77 | 0.76 |
VOD Novel P300 (P3a) | Cz, C1, C2, CPz, CP1, CP2 | 0.78 | 0.72 |
Mismatch Negativity | Fz, F1, F2, FCz, FC1, FC2 | 0.73 | 0.78 |
Event-related oscillation measures | |||
40-Hz ASSRd Inter-trial Coherence | FCZ, FC1, FC2, Cz, C1, C2 | 0.68 | 0.68 |
40-Hz ASSR Evoked Power | Fz, F1, F2, FCz, FC1, FC2 | 0.64 | 0.75 |
40-Hz ASSR Total Power | FCZ, FC1, FC2, Cz, C1, C2 | 0.67 | 0.65 |
Power spectral density measures | |||
Resting EEGe (eyes open): Delta | Fz, FCz | 0.80 | 0.77 |
Resting EEG (eyes closed) Delta | Fz, FCz | 0.86 | 0.79 |
Resting EEG (eyes open): Theta | Fz, FCz | 0.81 | 0.81 |
Resting EEG (eyes closed) Theta | Fz, FCz | 0.89 | 0.84 |
Resting EEG (eyes open): Alpha | Pz, P1, P2, POz, PO3, PO4 | 0.88 | 0.85 |
Resting EEG (eyes closed) Alpha | Pz, P1, P2, POz, PO3, PO4 | 0.85 | 0.79 |
Resting EEG (eyes open): Beta | AF3, AF4, F3, F4, F5, F6, POz, PO3, PO4 | 0.66 | 0.62 |
Resting EEG (eyes closed) Beta | AF3, AF4, F3, F4, F5, F6, POz, PO3, PO4 | 0.71 | 0.72 |
Resting EEG (eyes open): Gamma | AFz, AF3, AF4, Fz, F3, F4, F5, F6 | 0.54 | 0.52 |
Resting EEG (eyes closed) Gamma | AFz, AF3, AF4, Fz, F3, F4, F5, F6 | 0.44 | 0.49 |
Reaction time measures | |||
AOD Target Median Reaction Time | 0.68 | 0.78 | |
VOD Target Median Reaction Time | 0.67 | 0.79 | |